SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Cardiology (heart failure) Referral — Duke Kahanamoku

PatientDuke Kahanamoku
Date of birth1959-08-24
IdentifiersMRN HR-ML050-SYN; SSN (made up) 000-50-6847
Document date2026-03-16
AuthorKawika Lindgren-Morrison, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Six weeks of breathlessness, ankle swelling and tiredness in a 66-year-old Native Hawaiian man five years after a heart attack, with NT-proBNP 2,450 pg/mL, old anterior Q waves and an enlarged heart on chest X-ray. Please confirm the diagnosis and cause, advise on guideline-directed medical therapy and its order, the ischemic evaluation and device decisions, and how he can return to swimming and surfing safely. [S]

Urgency: Soon; on the day of his two-week visit, after the echocardiogram that morning. [S]

Questions for the consultant:

History of Present Illness

Sheriff of Honolulu and a lifelong swimmer and surfer; never smoked or drank. Heart attack five years ago treated with medicines; on aspirin 81 mg, atorvastatin 40 mg, metoprolol tartrate 25 mg twice daily and lisinopril 10 mg since then. Six weeks of breathlessness on slopes and while paddling, two-pillow orthopnea, evening ankle swelling and tiredness; NYHA class III. Today blood pressure 142/86, pulse 92, oxygen saturation 94%; jugular venous pressure 6 cm, basal crackles, 2+ ankle edema, soft S3. ECG: sinus rhythm, Q waves in V1 to V4, QRS 104 ms. Chest X-ray: enlarged heart, venous diversion, small effusions. NT-proBNP 2,450 pg/mL; sodium 138, potassium 4.2 mmol/L, creatinine 1.02 mg/dL (eGFR 81); hemoglobin 13.4 g/dL; ferritin 62 ng/mL, transferrin saturation 16%; TSH 2.1; hemoglobin A1c 5.9%; LDL 92 mg/dL. Started furosemide 40 mg daily and raised atorvastatin to 80 mg today. He wants his ʻohana involved in decisions as he chooses, and he makes the decisions [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet dailyOral route2021-06-21activeS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet dailyOral route2021-06-21 to 2026-03-16completedS
Atorvastatin 80 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-16activeS
Metoprolol tartrate 25 mg oral tablet, one tablet twice dailyOne tablet twice dailyOral route2021-06-21 to 2026-03-30completedS
Lisinopril 10 mg oral tablet, one tablet dailyOne tablet dailyOral route2021-06-21 to 2026-03-30completedS
Furosemide 40 mg oral tablet, one tablet every morningOne tablet every morningOral route2026-03-16 to 2026-04-27completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion for six weeks (paddling out, walking uphill, finishing his morning swim), with ankle swelling by evening and tiredness, five years after a heart attack; cause to be determinedactiveconfirmed R06.09S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology established heart failure with reduced ejection fraction.
Coronary artery disease with an old anterior myocardial infarction five years ago, treated with medicines; synthetic modern episode linked to the documented heart attack of 1952activeconfirmed I25.2S — Synthetic modern diagnosis; the 1952 heart attack remains D in the history.
Iron deficiency without anemia (ferritin 62 ng/mL, transferrin saturation 16%)activeconfirmed E61.1S — Synthetic finding at the heart failure workup.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1952Heart attack in 1952, at about 61, one of several in his later years; details of its treatment are not recorded in the sources readD (CLM-0009)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-16Body height185cmS
2026-03-16Body weight97.6kgS
2026-03-16Body mass index (BMI) [Ratio]28.5kg/m2S
2026-03-16Systolic blood pressure142mm[Hg]S
2026-03-16Diastolic blood pressure86mm[Hg]S
2026-03-16Heart rate92/minS
2026-03-16Respiratory rate20/minS
2026-03-16Body temperature36.7CelS
2026-03-16Oxygen saturation in Arterial blood by Pulse oximetry94%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-16Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma2450pg/mLBelow 125 pg/mL makes heart failure unlikely outside the hospitalHighS
2026-03-16Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-03-16Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-03-16Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-03-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M81mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-16Glucose [Mass/volume] in Serum or Plasma102mg/dL70-99 mg/dLHighS
2026-03-16Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.6-2.6 mg/dLNormalS
2026-03-16Hemoglobin [Mass/volume] in Blood13.4g/dL13.2-16.6 g/dLNormalS
2026-03-16Ferritin [Mass/volume] in Serum or Plasma62ng/mLIn heart failure, below 100 ng/mL, or 100 to 299 with transferrin saturation below 20%, is iron deficiencyLowS
2026-03-16Iron saturation [Mass Fraction] in Serum or Plasma16%20-50%LowS
2026-03-16Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.45-4.5 mIU/LNormalS
2026-03-16Hemoglobin A1c/Hemoglobin.total in Blood5.9%<=5.6%HighS
2026-03-16Cholesterol [Mass/volume] in Serum or Plasma168mg/dL<=199 mg/dLNormalS
2026-03-16Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation92mg/dLSecondary-prevention goal below 70 mg/dLHighS
2026-03-16Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
2026-03-16Triglyceride [Mass/volume] in Serum or Plasma160mg/dL<=149 mg/dLHighS
2026-03-16Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L7-55 U/LNormalS
2026-03-16Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-03-16Overall summary score [KCCQ-12]38{score}S

Assessment

Plan of Treatment